What is the correct dosage of Apelix? How to adjust dosage in different patient groups

Alpelisib is a targeted drug used to treat certain types of breast cancer. The following is the correct use and dosage of Apelix, as well as dosage adjustment recommendations for different patient groups.

The recommended initial dose of Apelvis is 300 mg (i.e. two 100 mg tablets or three 75 mg tablets) once daily, usually with food. To ensure absorption of the drug, patients are advised to take the drug with food and avoid taking it on an empty stomach. Patients should continue taking the drug at this dose until unacceptable adverse effects occur or the treatment is no longer effective. Apelix can be used in combination with other drugs, but the specific combination regimen should be based on the patient's specific condition.

During the treatment process, patients may experience some adverse reactions, such as hyperglycemia, rash, diarrhea, etc. If serious adverse reactions occur, your doctor may recommend reducing the dose or suspending the use of Apelix. For patients who need to adjust the dose due to drug side effects, a common adjustment plan is to reduce to 200mg once a day. If the patient tolerates it well, they can then gradually return to the original dose.

For patients with hepatic impairment, the dose of apelix needs to be adjusted based on specific liver function. For patients with mild to moderate hepatic impairment, it is usually recommended to maintain the regular dose; however, for patients with severe hepatic impairment, the dose needs to be reduced or used with caution under the guidance of a doctor. In addition, patients with renal insufficiency should also note that although Apelvis is mainly metabolized by the liver and has less impact on the kidneys, appropriate monitoring is still required based on the patient's specific conditions.

Apelix is often used in combination with other anti-cancer drugs, such as with tamoxifen (Tamoxifen) to treat breast cancer. In the case of combination therapy, dose adjustments need to be individualized based on the specific drugs used in the combination and the patient's response to treatment. If the combination results in more serious side effects or adverse reactions, the dose of apelix may need to be reduced or the drug may need to be temporarily discontinued. In addition, it is very important to regularly monitor blood sugar, liver function and other indicators so that drug dosage can be adjusted in a timely manner if necessary.

Overall, the usage and dosage of Apelvis should be individualized based on the patient's specific situation, severity of illness, and drug tolerance. During medication, patients should pay close attention to any adverse reactions and adjust the treatment plan according to the guidance of their doctor.

Reference materials:https://www.piqray.com/